Annick Desjardins

14PUBLICATIONS
135CO-AUTHORS
BiomaterialsMining, energy and natural resources lawInnate immunityGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 27, 2026
Anti-VEGF vascular remodeling drives germinal center B cell-rich tertiary lymphoid structures during antibody-toxin and anti-CD40 combination therapy in glioblastoma.

|Dec 01, 2025
STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma.

Howard Colman, Giuseppe Lombardi, Eric T Wong

|Nov 21, 2025
Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration.

Andrea L Ludwig, Zachary P McKay, Griffin P Carter

|Jun 12, 2025
A peptide vaccine targeting the CMV antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma: a phase 1 trial.

Eric M Thompson, David M Ashley, Katayoun Ayasoufi

|Jun 04, 2025
Predicting therapeutic clinical trial enrollment for adult patients with low- and high-grade glioma using supervised machine learning.

Mulki Mehari, Gayathri Warrier, Abraham Dada

|May 03, 2025
Response Assessment in Neuro-Oncology (RANO) 2009-2025: Broad scope and implementation-A progress report.

Martin J van den Bent, Michael A Vogelbaum, Tim Cloughesy

Pageof 3

Frequent Collaborators

4 joint publications

David M Ashley

3 joint publications

Henry S Friedman

2 joint publications

Patrick Y Wen

2 joint publications

Timothy F Cloughesy